GlaxoSmithKline Covid-19 drug falls short in trial, but may benefit older patients

GlaxoSmithKline Covid-19 drug falls short in trial, but may benefit older patients

Submitted by admin on February 25, 2021 - 9:53am
Source: 
Stat
News Tags: 
GSK
COVID-19
clinical trials
Headline: 
GlaxoSmithKline Covid-19 drug falls short in trial, but may benefit older patients
snippet: 

An experimental rheumatoid arthritis drug being developed by GlaxoSmithKline failed to show a significant benefit in hospitalized patients with Covid-19, the drug maker said Thursday.

Do Not Allow Advertisers to Use My Personal information